Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.54M Buy
13,060
+3,107
+31% +$359K 0.04% 359
2026
Q1
$1.19M Buy
9,953
+598
+6% +$78.4K 0.03% 397
2025
Q4
$1.27M Buy
9,355
+2,257
+32% +$325K 0.04% 371
2025
Q3
$1.05M Buy
+7,098
New +$984K 0.03% 415
2024
Q4
Sell
-1,555
Closed -$210K 1207
2024
Q3
$210K Sell
1,555
-107
-6% -$14.3K 0.01% 976
2024
Q2
$225K Sell
1,662
-76
-4% -$10.3K 0.01% 1008
2024
Q1
$225K Buy
+1,738
New +$210K 0.01% 1031

Other funds holding XYL

Wedbush Securities's XYL Position: Q2 2026 in Review

Wedbush Securities increased its Xylem (XYL) stake by 31% in Q2 2026, buying an estimated $359K and bringing the position to 13,060 shares worth $1.54M. The position accounts for 0.04% of the portfolio, ranked #359.

Wedbush Securities first reported a position in XYL in Q1 2024 and has held it in 7 quarters since. 1,098 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Wedbush Securities held 13,060 shares of Xylem worth $1.54M as of Q2 2026.
  • Wedbush Securities bought 3,107 Xylem shares in Q2 2026, an estimated $359K.
  • Xylem made up 0.04% of Wedbush Securities's portfolio in Q2 2026, its #359 holding.
  • Wedbush Securities first reported a position in Xylem in Q1 2024 and has held it in 7 quarters since.
  • 1,098 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Wedbush Securities's 13F filing for Q2 2026, filed 28 Jul 2026.